Previous Article | Next Article ![]()
Journal of Clinical Microbiology, Feb 1995, 477-480, Vol 33, No. 2
E Valentine-Thon
The sensitivity, specificity, reproducibility, detection level, and
quantification potential of the SHARP Signal System for enzymatic detection
of amplified hepatitis B virus (HBV) DNA in clinical samples were evaluated
by testing 104 samples in parallel in a SHARP PCR, an in- house HBV PCR,
and a dot blot hybridization assay for semiquantification. SHARP PCR showed
a sensitivity of 100%, a specificity of 92.3% (resolved, 100%), a
reproducibility of 92.3% (all discrepant serum samples involved very low
levels of HBV DNA), and a detection level of at least 3.5 pg/ml. Clinically
relevant quantification of the amplified products was not feasible.
Copyright © 1995 by the American Society for Microbiology. All rights reserved.
Evaluation of SHARP signal system for enzymatic detection of amplified hepatitis B virus DNA
Labor Schiwara, von Winterfeld, Pfanzelt, Kunz, Bremen, Germany.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|